13FPulse
中
UT

UTHR UNITED THERAPEUTICS CORP

2026Q2 · CUSIP 91307C102 · Sector: Healthcare & Biotech

Normal

Fund flows are within the usual range

Funds that own it
853
Institutions that reported holding it to the SEC
Net increase in holders
+8
Last quarter 845 → now 853
How unusual is that
Above average
Stronger buying than 65% of US stocks
What the filings say, in one paragraph

853 funds held UTHR at the end of 2026Q2, up 8 from the quarter before. Fund flows are within the usual range — nothing unusual. On the business itself, revenue over the last 12 months was $3.2B(YoY +2.5%), the P/E is 17.6x, return on equity is 20.5%. UTHR has had 20 buying rushes in its history, and the price moved +2.4% on average over the six months after (that is the raw price move, not how much it beat the market by). It sits in the Healthcare & Biotech sector.

How many funds owned it, quarter by quarter

Bars = net change in institutional holders, positive (green) or negative (red). Line = total institutional holders.

2013Q3: holders=282 2013Q4: holders=308 2014Q1: holders=298 2014Q2: holders=294 2014Q3: holders=312 2014Q4: holders=327 2015Q1: holders=359 2015Q2: holders=371 2015Q3: holders=360 2015Q4: holders=374 2016Q1: holders=393 2016Q2: holders=376 2016Q3: holders=381 2016Q4: holders=395 2017Q1: holders=402 2017Q2: holders=363 2017Q3: holders=363 2017Q4: holders=393 2018Q1: holders=372 2018Q2: holders=366 2018Q3: holders=362 2018Q4: holders=355 2019Q1: holders=370 2019Q2: holders=317 2019Q3: holders=297 2019Q4: holders=314 2020Q1: holders=298 2020Q2: holders=344 2020Q3: holders=329 2020Q4: holders=350 2021Q1: holders=388 2021Q2: holders=396 2021Q3: holders=421 2021Q4: holders=411 2022Q1: holders=425 2022Q2: holders=468 2022Q3: holders=458 2022Q4: holders=512 2023Q1: holders=503 2023Q2: holders=472 2023Q3: holders=508 2023Q4: holders=535 2024Q1: holders=522 2024Q2: holders=567 2024Q3: holders=620 2024Q4: holders=669 2025Q1: holders=667 2025Q2: holders=667 2025Q3: holders=702 2025Q4: holders=831 2026Q1: holders=845 2026Q2: holders=853 -129 -64.5 +0 +64.5 +129 253575896 13Q315Q116Q318Q119Q321Q122Q324Q125Q326Q2 Net change in holders (bars) Total funds holding (line)

What happened after each past buying rush 20 times in its history

Quarter of the rush How unusual then Price, next 3 months Price, next 6 months
2025Q4 Top 5% +16.5% +17.4%
2025Q3 Top 10% +5.3% +1.8%
2024Q4 Top 10% -17.2% -17.6%
2024Q3 Top 5% -0.8% +0.5%
2024Q2 Top 5% +11.5% +20.3%
2023Q3 Top 5% +0.7% -5.5%
2022Q4 Top 10% -10.4% -13.8%
2022Q2 Top 5% -5.5% +16.9%

These are the raw price moves, not how much it beat the market by. Compare them against the market over the same months — in a strong bull market almost everything is up.

Show all the numbers (large funds, value held, options…) ▾
Of them, large funds
308
Change in large funds
+27
Total value they hold
$22.5B
Funds buying for the first time
107
Funds that sold out entirely
99
Price change that quarter
-13.2%
Funds holding puts (bearish)
8
Funds holding calls (bullish)
8

These are for people who want to dig. Skip them if they do not mean anything to you — the three numbers above are enough.

8,697 institutions have filed for this quarter. 13F permits late filing and a small number arrive in the weeks after the deadline, so the holder counts and changes below may tick up.

Fundamentals

PE (TTM)
17.6
EPS (TTM)
$27.91
EPS YoY
+8.8%
Revenue (TTM)
$3.2B
Revenue YoY
+2.5%
Net margin
41.6%
ROE
20.5%
Debt ratio
11.3%
FCF (TTM)
$1.1B
Dividend (TTM)
No dividend
Quarterly Revenue & EPS
2021-09-30: EPS 3.42 2021-12-31: EPS 2.38 2022-03-31: EPS 5.03 2022-06-30: EPS 2.41 2022-09-30: EPS 4.91 2022-12-31: EPS 2.65 2023-03-31: EPS 4.86 2023-06-30: EPS 5.24 2023-09-30: EPS 5.38 2023-12-31: EPS 4.33 2024-03-31: EPS 6.17 2024-06-30: EPS 5.85 2024-09-30: EPS 6.39 2024-12-31: EPS 6.23 2025-03-31: EPS 6.63 2025-06-30: EPS 6.41 2025-09-30: EPS 7.16 2025-12-31: EPS 7.66 2026-03-31: EPS 5.82 2026-06-30: EPS 7.27 0M 400M 800M $M 0.00 4.21 8.43 2016201720182019202020212022202320242025202606/26 Revenue EPS

Quarterly figures, revenue up to 10 years back; EPS split-adjusted, early quarters hidden when not calibrable

P/E (TTM) over time
4Y median 15 10 16 22 20222023202420252026

P/E = close around day 47 after quarter-end ÷ TTM EPS then; this is a consistent valuation date, not the company’s actual filing date; loss quarters hidden

Quarterly free cash flow
-653M-133M386M 20162017201820192020202120222023202420252026
Latest quarter $363M (2026-03-31)

FCF = operating cash flow − capex, computed from SEC XBRL; banks/insurers have no standard cash-flow structure and are hidden

As of 2026-06-30 · SEC filings (XBRL)

Email me the next update

2026 Q3 holdings are due 2026-11-16. We will email you when the refreshed lists are live.